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ABSTRACT
The prediction of transcription factor binding sites
in genomic sequences is in principle very useful to
identify upstream regulatory factors. However,
when applying this concept to genomes of multi-
cellular organisms such as mammals, one has to
deal with a large number of false positive predic-
tions since many transcription factor genes are
only expressed in specific tissues or cell types. We
developed TS-REX, a database/software system
that supports the analysis of tissue and cell type-
specific transcription factor-gene networks based
on expressed sequence tag abundance of transcrip-
tion factor-encoding genes in UniGene EST libraries.
The use of expression levels of transcription factor-
encoding genes according to hierarchical anatomi-
cal classifications covering different tissues and
cell types makes it possible to filter out irrelevant
binding site predictions and to identify candidates
of potential functional importance for further
experimental testing. TS-REX covers ESTs from
H. sapiens and M. musculus, and allows the charac-
terization of both presence and specificity of tran-
scription factors in user-specified tissues or cell
types. The software allows users to interactively
visualize transcription factor-gene networks, as
well as to export data for further processing.
TS-REX was applied to predict regulators of
Polycomb group genes in six human tumor tissues
and in human embryonic stem cells.
INTRODUCTION
The state of a normal or diseased cell is determined by
external signals and by its intrinsic gene expression pat-
tern. Transcription factors (TFs) are major regulators of
gene expression, typically controlling more than one gene
and acting in concert. Such TF-gene interactions can be
described as networks, which are crucial to understand
hierarchies of gene expression regulation. The identiﬁca-
tion of TF binding sites (TFBSs) in genomic DNA
sequences has played an important role in predicting tran-
scriptional networks. A large number of TFs binds to spe-
ciﬁc DNA sequence stretches with a length of 5–25bp (1),
which have been experimentally determined and have
served to deﬁne motifs that are often used for in silico
binding site prediction. This is typically done by searching
gene sequences for DNA stretches appearing more often
than expected based on a background DNA model (2).
A fundamental problem in building TF-gene networks
based on binding motifs in DNA sequences of putative
target genes is the rate of false positive predictions of
TFBSs (3). Diﬀerent errors account for such false positive
predictions. One error is based on the probability of
occurrence of short sequence motifs in large stretches of
genomic DNA. To reduce this error, the motif search can
be restricted to genomic DNA sequences which are con-
served among species. This strategy is based on the
assumption that DNA stretches playing a crucial biolog-
ical role may be evolutionarily conserved (4). Therefore,
several methods for the prediction of TFBSs only consider
conserved DNA sequence blocks (2,5–7). A second error is
based on the fact that although a TFBS might be correctly
predicted, binding of the respective factor might only
*To whom correspondence should be addressed: Tel: +46 46 2221563; Fax: +46 46 2223600; Email: ulrike.nuber@med.lu.se
The authors wish it to be known that, in their opinion, the second and third authors should be regarded as joint Second Authors.
 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.occur in certain cells or tissues. This is either because the
factor itself is not expressed or because additionally
required co-factors are missing. The error that is related
to the absence of a TF in a given tissue or cell type can be
reduced by ﬁltering predicted TFs based on their expres-
sion in the tissue or cell type of interest.
Both tissue speciﬁcity of gene expression proﬁles and
the combination of TFBS information with gene expres-
sion data are the focus of a number of databases and
software tools. The closest to TS-REX in terms of objec-
tives and scope are MatInspector (8,9), the Promoter
Analysis Pipeline (10,11) and the method described by
Jeﬀery et al. (12). MatInspector allows TFBS prediction
based on position weight matrix families, and includes
tissue associations of the respective TFs. The focus of
the other two tools is to identify TFBSs that are associated
with co-regulated genes. Jeﬀery and colleagues particu-
larly aim to ﬁnd diﬀerences in TFBS occurrence between
sets of diﬀerentially expressed genes.
However, none of the above-mentioned tools combines
knowledge of TF expression levels with binding site pre-
diction tools in order to allow extraction of tissue-speciﬁc
portions of predicted TF-gene networks. The value of our
approach stems both from its potential to address the
problem of reducing false positive rates in in silico binding
site prediction as previously mentioned, and from its pro-
spective contribution to eﬀorts aiming at a systems-level
characterization of transcriptional regulation via a combi-
nation of network-based analytical techniques with ana-
tomical annotations (13,14).
We have therefore developed a new resource, called
Tissue-Speciﬁc Regulatory Network Extractor (TS-
REX), consisting of a TF tissue database and a client–
server software tool for the visualization of tissue and
cell type-speciﬁc TF-gene networks based on TF expres-
sion levels. TS-REX extracts and displays tissue and cell
type speciﬁcity of TF-gene networks. In addition to the
availability of a direct interface to TFBS prediction
tools such as TOUCAN (2,7), one distinctive feature of
TS-REX is the richness of its anatomical classiﬁcation,
namely a newly established order of UniGene expressed
sequence tag (EST) libraries, which allows a ﬁne-grained
dissection of TF-gene networks based on quantitative
information about TF expression on an anatomical basis.
The TS-REX database comprises both quantitative esti-
mates of tissue speciﬁcity obtained from UniGene EST
library data and a comprehensive manually reﬁned hier-
archical anatomical classiﬁcation. ESTs from both
H. sapiens and M. musculus are covered.
The TS-REX software visualizes TF-gene networks and
allows users to select anatomical structures such as tissues
and cell types from the TS-REX hierarchical classiﬁcation
or from a user-provided input ﬁle containing tissue anno-
tations, in order to highlight those TFs that are present in
or speciﬁc to tissues or cell types of interest. To facilitate
the assessment of diﬀerent degrees of tissue or cell type
speciﬁcity of TFs, the software also provides the user with
a signiﬁcant amount of ﬂexibility in terms of parameter
choice, as well as with the possibility to export data for
further analysis.
TS-REX is a web-based tool with the database main-
tained at Lund University. Users can upload their input
ﬁles to the TS-REX server via a graphical user interface,
and queries to the database are transparently performed
by the software. An overview is provided in Figure 1,
together with an indication of the way the system is
supposed to be used.
The TS-REX client can be launched from http://
kundera.thep.lu.se:8080/TSREX/TSREX.jnlp (Java 1.6 is
required, which currently makes TS-REX available under
the Windows and Linux platforms).
MATERIALS AND METHODS
Database
The following sections describe the individual steps that
led to the generation of the TS-REX database.
Establishment of a hierarchical classification based on
UniGene EST libraries. The TS-REX hierarchical classiﬁ-
cation associates each EST library identiﬁer with a library
group based on which tissue or cell type that library cor-
responds to.
A two-step procedure was followed to build the classi-
ﬁcation. Perl scripts were used to parse the online tissue-
related information that UniGene provides for a number
of EST libraries, in order to extract available anatomical
annotations. The data generated by this automated pro-
cedure subsequently underwent an extensive manual revi-
sion and editing process, in order to have each library
Figure 1. Overview of TS-REX. Users have access to a graphical user
interface that communicates with the server-side component of the
TS-REX software, which in turn performs queries to the database at
Lund University. The user-provided primary input ﬁle, which can be
either an output ﬁle from MotifScanner or a tab delimited text ﬁle
containing a correspondence between target genes and TRANSFAC
identiﬁers of predicted TF proteins, is processed by the network viewer
module. Two alternatives are then available: the software uses either
the TS-REX database to identify TFs present in or speciﬁc to tissues or
cell types of interest, or an auxiliary user-provided ﬁle reporting genes
that are known to be expressed in diﬀerent tissues. The latter option
allows the extraction of expressed TF genes from the user’s own data
on rare tissues or cells that are not contained in the TS-REX database.
The tissue browser makes it possible to select tissues and cell types of
interest, and to export ﬁles for subsequent analysis.
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included organizing tissue-related information into a hier-
archical, comprehensive, ﬁne-grained classiﬁcation, com-
prising multiple categories corresponding to diﬀerent
aggregation levels, namely pathologies, systems, organs,
tissues and cell types.
All those EST libraries that (i) were available via the
UniGene Library Browser, (ii) contained at least one EST
sequence and (iii) were considered as biologically relevant
were included in the TS-REX classiﬁcation, excluding
normalized and subtracted libraries. This corresponds to
604 murine and 5708 human libraries.
Assignment of EST counts to library identifiers. UniGene
data (Hs.data and Mm.data ﬁles from the NCBI FTP
website corresponding to UniGene builds #201 and
#162, respectively) were downloaded and processed in
order to extract lists of EST sequence identiﬁers associated
with the various genes in the diﬀerent EST libraries. The
murine database comprises 82105 UniGene clusters and
4029157 EST sequence identiﬁers, while the human one
contains 123993 UniGene clusters and 6509336 EST
sequence identiﬁers. For each library identiﬁer, an EST
count was obtained for every gene as the number of
EST sequences corresponding to that gene in that library.
Calculation of p-values and transcripts-per-million of
UniGene clusters for different library groups. P-values
were determined using a binomial model to calculate the
probability for a given gene to be associated with the
observed number of ESTs or more (15), corresponding
to a given entry in the anatomical hierarchy (e.g. a given
organ, tissue or cell type) under the hypothesis that the
gene considered is unspeciﬁc. Namely, the p-value corre-
sponding to gene g and entry i in the hierarchy was calcu-
lated according to:
pig ¼
X Eg
x¼eig
Eg!
x!ðEg   xÞ!
px
i ð1   piÞ
Eg x 1
where eig is the sum of the EST counts for gene g in all
libraries associated with anatomical structure i, Eg is the
total number of EST sequences in the database for gene g,
and pi is the fraction of EST sequences corresponding to i.
If si represents the total number of EST sequences corre-
sponding to i, i.e. if si ¼
P
g eig, then
pi ¼
si P
j
sj
2
For instance, if the items considered in the hierarchical
classiﬁcation are cell types, each p-value in Equation (1)
represents the probability for gene g to correspond to a
number of EST sequences in cell type i at least equal to the
observed one under the assumption that all cell types are
equivalent, i.e. that g does not exhibit any cell type speci-
ﬁcity. If the p-value for the encoding gene of a TF in a
given cell type according to Equation (1) is lower than a
given threshold, the corresponding TF protein is consid-
ered to be speciﬁc to that cell type.
While the binomial approach presented above can be
used to determine tissue speciﬁcity, it is not suited to esti-
mate whether the number of EST sequences of a TF-
encoding gene is high enough for the corresponding TF
to be considered as present in the selected anatomical
structures. Instead EST counts were used to calculate
the number of transcripts-per-million (TPM) for gene g
corresponding to anatomical structure i, according to:
TPMig ¼
eig
si
3
For instance, a TF is classiﬁed by TS-REX as present in a
given cell type if the TPM score of its TF-encoding gene
corresponding to that cell type exceeds a user-speciﬁed
threshold.
Generation of the TS-REX encoding datasets. The corre-
spondence between TFs and their encoding genes is a cru-
cial component of TS-REX. The TS-REX encoding
datasets incorporate this information for all TFs reported
in TRANSFAC (1,16) for both H. sapiens and M. mus-
culus. TS-REX allows users to authenticate both to the
publicly available version of TRANSFAC, for which
access is provided via free registration at www.gene-regu
lation.com, and to the licensed version of TRANSFAC.
Users who authenticate to the latter can make use of the
complete TS-REX encoding datasets; otherwise, TS-REX
uses a subset of the encoding datasets corresponding to
those TFs that are reported in the public version of
TRANSFAC. The publicly available and the licensed
versions of TRANSFAC will be referred to as
TRANSFAC Public and TRANSFAC Professional in
the following.
The TS-REX encoding datasets were obtained using
information from TRANSFAC Professional 11.1, and
from the Hs.data and Mm.data ﬁles provided by
UniGene at www.ncbi.nlm.nih.gov. Namely, the encoding
datasets were obtained according to the procedure
detailed as follows:
(i) TRANSFAC data were used to extract an associ-
ation between TFs reported in TRANSFAC (for
H. sapiens and M. musculus) and the RefSeq identi-
ﬁers of the corresponding encoding genes. Subse-
quently, Hs.data and Mm.data from UniGene
were parsed, and the previously found RefSeq iden-
tiﬁers were used to extract the UniGene identiﬁer(s)
of the encoding gene. This matching procedure was
necessary due to UniGene identiﬁers being periodi-
cally revised and changing over time: the UniGene
identiﬁers that are internally used by TS-REX cor-
respond to UniGene builds #201 and #162 for
H. sapiens and M. musculus, respectively (‘TS-
REX UniGene IDs’ in the following).
(ii) For those TRANSFAC TFs for which no RefSeq-
based match to UniGene could be found, the TS-
REX UniGene ID(s) of the corresponding encoding
gene was (were) retrieved by searching the TS-REX
naming dataset (see description below) for the gene
symbol provided by TRANSFAC. Only UniGene
clusters containing at least one RefSeq identiﬁer
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resulted in no TF-encoding genes being provided.
(iii) The TS-REX UniGene IDs of the encoding genes of
those TFs that did not have any RefSeq identiﬁers
in TRANSFAC were also retrieved based on gene
symbol, as described above. As in step (ii), only
UniGene clusters associated with at least one
RefSeq identiﬁer were included for the TF-encoding
genes, unless this resulted in no TF-encoding genes
being provided.
Generation of the TS-REX naming dataset. TS-REX uses
an internal representation for genes and TFs that is based
on TS-REX UniGene IDs and TRANSFAC TF identi-
ﬁers. However, the software also displays gene and factor
names, as previously described. In order for this to be
possible, TS-REX includes a mapping between TS-REX
UniGene IDs or TRANSFAC TF identiﬁers and the
corresponding gene symbols or TF names from
UniGene and TRANSFAC, respectively, for both
H. sapiens and M. musculus.
Software
A combination of technologies including Java
TM, Perl and
SQL was used for the development of the TS-REX soft-
ware. Additional notes on the implementation of the TS-
REX software are provided at TS-REX startup.
Use of TS-REX is not recommended on computers with
less than 1GB RAM. Performance, in particular with ref-
erence to interactive network visualization, is also aﬀected
by network size, depending on computer speciﬁcations.
Polycomb group gene application
Human and murine DNA sequences for Enhancer of zeste
homolog 2 (EZH2), Suppressor of zeste 12 homolog
(SUZ12), and Polycomb complex protein BMI-1 (BMI1)
corresponding to conserved regions between the two spe-
cies of  2000bp around the transcriptional start site were
retrieved using the VISTA Browser [http://pipeline.lbl.
gov, (17)] and the UCSC Genome Browser [http://
genome.ucsc.edu, (18)]: Human Mar. 2006 chr7:
148211087-148212876 and Mouse Feb. 2006 chr6:
47523460-47525135 for EZH2; Human Mar. 2006 chr10:
22649733-22651591 and Mouse Feb. 2006 chr2: 18594320-
18596071 for BMI1; Human Mar. 2006
chr17:27287892-27289964 and Mouse Feb. 2006 chr11:
79809025-79811009 for SUZ12. We applied
MotifScanner 3.1.1 (http://homes.esat.kuleuven.be/
 thijs/Work/MotifScanner.html) for binding site predic-
tion using matrix ﬁles from TRANSFAC Professional
11.1 (for H. sapiens and M. musculus separately), as well
as murine and human conserved non-coding sequences as
a background model (namely, the ﬁle hsmmCNS_
ens36_3.bg was used). The MotifScanner parameter
choice corresponded to a double-stranded search with p
set to 0.5 (p is a parameter between 0 and 1, higher values
allowing higher motif degeneracy). A detailed documenta-
tion of MotifScanner is available at http://homes.esat.
kuleuven.be/ thijs/help/help_motifscanner.html.
Cells and culture conditions
The human cervix carcinoma cell line Hela was grown in
Dulbecco’s Modiﬁed Eagle’s Medium and the human
colon adenocarcinoma cell line SW480 in RPMI-1640
medium (Invitrogen) at 378Ci n5 %C O 2 in air. Media
were supplemented with 10% heat-inactivated FBS and
1% penicillin/streptomycin. To activate expression of
early growth response 1 (EGR1), cells were treated with
10ng/ml phorbol 12-myristate-13-acetate (PMA; Sigma)
for 2h.
Quantitative PCR
RNA was isolated using an RNA preparation kit
(QIAGEN) according to the manufacturer’s instructions.
For cDNA synthesis, 2mg of total RNA were treated with
2U RNase free DNase (Promega) to prevent DNA con-
tamination followed by reverse-transcription at 378C
for 90min with 2ml M-MLV Reverse Transcriptase
(Promega, 200U/ml) and 2ml oligo-dT-primer (TIB
Molbiol, 20pmol/ml) in a volume of 40ml. After cDNA
synthesis, samples were diluted to 100ml. Quantitative
PCR (qPCR) was performed using the iQ5 Real-Time
PCR system (Bio-Rad). A 20ml reaction contained 1ml
cDNA, 0.1mM of the forward and reverse primers and
10ml of the Power SYBR Green PCR Master Mix
(Applied Biosystems). Reactions were done in triplicates.
The following primers were used for target gene expres-
sion analysis:
EZH2 forward (50-AGGACGGCTCCTCTAACCAT-30),
EZH2 reverse (50-CTTGGTGTTGCACTGTGCTT-30),
SUZ12 forward (50-CAGCTCATTTGCAGCTTA
CG-30), SUZ12 reverse (50-CGGGTTTTGTTTGATTG
AGG-30), BMI1 forward (50-ATGCCCAGCAGCAATG
AC-30), and BMI1 reverse (50-CTCCAGCATTTGTCAG
TCCA-30).
Primers for EGR1 transcript level measurements were:
EGR1 forward (50-AGCCCTACGAGCACCTGAC-30),
and EGR1 reverse (50-AGCGGCCAGTATAGGTGA
TG-30).
For normalization, expression analyses of diﬀerent
housekeeping genes, Beta-2-microglobulin (B2M) and
TATA box-binding protein (TBP) were performed
using the primers B2M forward (50-CGAGACATGTA
AGCAGCATCA-30), B2M reverse (50-CAAACATGGA
GACAGCACTCA-30), TBP forward (50-ACAACAGCC
TGCCACCTTAC-30), and TBP reverse (50-GCCTTTGT
TGCTCTTCCAAA-30).
The reaction proﬁle was as follows: 10min at 958C, 40
cycles of 15s at 958C and 60s at 608C. CT values were
determined by the Bio-Rad iQ5 software (version 2.0).
Relative expression levels were evaluated using the
  CT method comparing CT values of the target gene
with CT values of the housekeeping genes.
Transfection
For over-expression studies, 2 10
5cells were plated onto
six-well tissue culture plates and transiently transfected
with 2mg EGR1 expression vectors (pCMV-EGR1) (19)
or with empty vectors (pCMV5) as negative control using
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Western blot analysis
Fifty micrograms of whole cell lysates were separated by
SDS–PAGE and transferred to a nitrocellulose membrane
(Macherey-Nagel, Du ¨ ren, Germany). Membranes were
blocked with 5% milk powder (Roth, Karlsruhe,
Germany) and probed with rabbit polyclonal antibodies
against EGR1 (Santa Cruz) or b-Actin (Sigma). Goat per-
oxidase-coupled anti-rabbit IgG (Promega) was used as
secondary antibody.
Chromatin immunoprecipitation (ChIP)
Cells were treated with 1% formaldehyde for 10min at
room temperature to cross-link DNA to chromatin-asso-
ciated proteins. Reactions were terminated by adding gly-
cine (ﬁnal concentration 0.125M). Cells were harvested
and resuspended in SDS lysis buﬀer (1% SDS, 10mM
EDTA, 50mM Tris–HCl pH 8.1) and protease inhibitors
(1mM PMSF, 1mg/ml aprotinin and 1mg/ml leupeptin).
To shear DNA, cells were sonicated three times for 30s at
20% amplitude (Branson Soniﬁer W-250D) and centrifu-
gated at 12000 g for 10min at 48C. The supernatants
were diluted in 10  ChIP dilution buﬀer (0.01% SDS, 1%
Triton X-100, 2mM EDTA, 16.7mM Tris–HCl pH 8.1
and 167mM NaCl) and protease inhibitors as above.
Samples were incubated with 2mg anti-EGR1, IgG or no
antibody at 48C overnight with rotation. Thirty microli-
ters of salmon sperm DNA/protein A-agarose slurry
(Sigma) was added and incubated at 48C for 1h. The
immune complex-binding agarose beads were collected
by centrifugation and washed sequentially. DNA was
eluted with 1% SDS, 0.1M NaHCO3 and reverse cross-
linked by heating at 658C for 4h after the addition of
NaCl (ﬁnal concentration 0.2M). Before immunoprecipi-
tation, a small chromatin-protein sample was excluded
and used as input sample for a positive PCR control.
DNA was puriﬁed using QIAquick puriﬁcation kit
(Qiagen) according to the manufacturer’s instructions.
The immunoprecipitated DNA was analyzed by semi-
quantitative PCR with an annealing temperature of 588C
for 36 cycles using primers spanning EGR1-binding
motifs:
EZH2 AE forward (50-CTCCACTGCCTTCTGAGT
CC-30), EZH2 AE reverse (50-GGGCCAAATAAAAGC
GATG-30), SUZ12 AF forward (50-GTGACTGACGGG
GGAATC-30), SUZ12 AF reverse (50-AGGGAAGGAG
GGAGGAAAA-30), SUZ12 Q forward (50-CGAGCGG
TTGGTATTGCAG-30), SUZ12 Q reverse (50-AGGAGG
AGGCCGAGTAACTG-30), BMI1 AB forward (50-CCC
CCACAGCAACTATGAAA-30), BMI1 AB reverse (50-G
CGCGATCGGTTTTATTCT-30), BMI1 AC forward
(50-CTTGGCTCGCATTCATTTTC-30), and BMI1 AC
reverse (50-CTACGTACCCGGAAAGAGCA-30).
All PCR reactions were performed in triplicates and
quantiﬁed by densitometric evaluation of signal intensity
using the NIH image software.
RESULTS
Establishment of a database containing tissue and
cell type-specific gene expression information based
on mouse and human UniGene EST libraries
We generated a database containing quantitative estimates
of gene expression information at diﬀerent anatomical
levels, starting from murine and human EST library
data provided by UniGene. The processing of these pri-
mary data, together with the development of an extensive
anatomical classiﬁcation and with the corresponding
annotation of all relevant UniGene EST libraries, led to
the establishment of a database quantifying gene expres-
sion on a ﬁne-grained hierarchical anatomical basis.
Expression level information is stored in the TS-REX
database for each UniGene cluster that is associated
with at least one EST sequence in an EST library included
in the hierarchical classiﬁcation.
This classiﬁcation is the result of a manual editing pro-
cess aimed at (i) grouping anatomical structures into a
ﬁne-grained ontology in terms of pathologies, systems,
organs, non-tumor tissues or tumor types (‘tissues’ in the
following) and cell types, and (ii) mapping relevant
UniGene EST libraries to the corresponding entry in
the classiﬁcation. Normalized and subtracted EST
libraries were excluded. Each of the two pathology-
related categories that are represented in the classiﬁca-
tion, namely ‘non-tumor’ and ‘tumor’, is the root of
a hierarchy that spans four diﬀerent aggregation levels,
the most ﬁne-grained structures corresponding to cell
types.
An extract from the human hierarchical classiﬁcation is
displayed in Figure 2.
Since the focus of TS-REX is tissue or cell-based dissec-
tion of TF-gene networks, the TS-REX software only
makes use of the portion of the TS-REX database that
corresponds to those genes that are reported to encode at
least one TF in TRANSFAC.
Most TRANSFAC TF identiﬁers are covered by the
TS-REX database (Supplementary Figure 1A and B),
namely 1443 out of 1539 for H. sapiens, and 1080 out of
1128 for M. musculus.
Table 1 summarizes the total numbers of EST sequences
and UniGene clusters included in the TS-REX database
for H. sapiens and M. musculus, as well as the numbers of
available pathologies, systems, organs, tissues and cell
types in the hierarchical classiﬁcation.
We designed TS-REX to allow a quantitative character-
ization of both presence and speciﬁcity of TFs relative to a
given anatomical selection. For this reason, we stored dif-
ferent estimates of gene expression in the TS-REX data-
base to be used with regards to either presence or
speciﬁcity according to the user’s parameter choice.
More precisely, TS-REX quantiﬁes presence of TFs in a
set of anatomical structures in terms of transcripts per
million (20), while speciﬁcity is characterized based on
p-values calculated from the EST counts of the corre-
sponding encoding genes, as detailed in ‘Materials and
Methods’.
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through a web-based software
The TS-REX software is meant to be used in conjunction
with existing TFBS prediction tools, for example
TOUCAN, in order to highlight those TFs that are pres-
ent in or speciﬁc to anatomical structures of interest, such
as tissues or cell types, in the context of predicted TF-gene
networks. Alternatively, other datasets of TF-target gene
interactions can be used (see ‘Data input formats’ below).
A combination of technologies was used to develop the
TS-REX software, both in order to meet speciﬁc require-
ments (e.g. for development of graphical user interfaces,
for network visualization, and for string processing)
and in order to base the system on cross-platform
technologies.
The workﬂow is divided into the following steps:
(1) Choose whether to use the public or the licensed
version of the TRANSFAC database, and log in
from TS-REX.
(2) Provide an input ﬁle containing TFBS prediction
results, which subsequently gets uploaded to the
TS-REX server for further processing.
(3) Visualize the corresponding TF-gene network.
(4) Use the TS-REX tissue browser to select anatomical
structures of interest.
(5) Visually present those predicted TFs that satisfy the
selection criteria speciﬁed at step 4.
(6) Export data for further analysis.
TS-REX also includes a demonstration feature that
allows users to visualize a network from the Polycomb
group gene (PcG) analysis without authentication to
TRANSFAC. In this case, a TF-gene network corre-
sponding to TF proteins present in glioma and/or in neu-
roblastoma is used, and only TFs reported in
TRANSFAC Public can be highlighted.
Authentication to TRANSFAC. This section describes
the authentication procedure to TRANSFAC from the
TS-REX software. At application startup, the user is
required to choose between the public and the licensed
version of the TRANSFAC database. TRANSFAC
contains information about TFs, including the corre-
sponding encoding genes and statistical descriptions of
the nucleotide composition of their binding sites. It is
often used in conjunction with TFBS prediction tools.
Figure 2. Extract from the TS-REX human hierarchical classiﬁcation. Individual UniGene EST library identiﬁers (column 1) are associated with
anatomical categories speciﬁed in terms of pathologies, systems, organs, tissues and cell types whenever possible (columns 2–6).
Table 1. Summary of the total numbers of EST sequences and
UniGene clusters included in the TS-REX database, and of the
numbers of pathologies, systems, organs, tissues and cell types
included in the TS-REX hierarchical classiﬁcation
H. sapiens M. musculus
Total number of ESTs 6509336 4029157
Total number of UniGene clusters 123993 82105
Number of pathologies (non-tumor, tumor) 2 2
Number of systems 16 16
Number of organs 62 48
Number of tissues 155 75
Number of cell types 44 64
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TRANSFAC Professional 11.1 for H. sapiens and M.
musculus. In order for the system to make use of these
data without any restrictions, users must log into the
online version of TRANSFAC Professional via the
TS-REX authentication module. Authentication to
TRANSFAC Public is also possible, and results in the
TS-REX software retrieving information from the TS-
REX database for the encoding genes of those TFs that
correspond to publicly available TRANSFAC records
only. Authentication to either TRANSFAC Public or
TRANSFAC Professional is required in order to use
TS-REX, with the exception of the demonstration feature.
The development of the authentication module of TS-
REX was inspired by a similar functionality available in
the PAINT software (21). The ﬁle formats that TS-REX
accepts as input are described below.
Data input formats. TS-REX requires the user to provide
an input ﬁle in one of two possible forms:
(i) A ﬁle exported from TOUCAN, containing the
results of a TFBS prediction using MotifScanner
with TRANSFAC as motif database (2,7,22,23),
or
(ii) A tab delimited text ﬁle containing two columns,
namely (a) a target gene list, and (b) a list of the
TRANSFAC identiﬁers of the corresponding TFs
that were predicted to regulate those genes using
other binding site prediction tools.
When an input ﬁle of the ﬁrst type is provided, it is
automatically processed by the TS-REX software and
converted into an internal data representation equivalent
to an input ﬁle of the second type. This process is com-
pletely transparent to the user. An input ﬁle of either type
will be referred to as ‘primary input ﬁle’ in the following.
As an alternative to using the TF gene expression infor-
mation that is stored in the TS-REX database according
to a hierarchical classiﬁcation of anatomical structures,
TS-REX also allows the user to provide an additional
tab delimited text ﬁle (‘auxiliary ﬁle’ in the following).
This option can be used in case users are interested in
TF-gene networks of rare tissues or cell types that are
not represented in the TS-REX database but for which
gene expression information can be provided by the
users themselves. TS-REX identiﬁes TF-encoding genes
in a list of genes (auxiliary ﬁle) that are expressed in
such tissues or cell types. The auxiliary ﬁle can contain
up to ﬁve gene lists, each of them reporting the
UniGene gene symbols of genes that are known to be
expressed in the corresponding tissue or cell type. Each
of these lists can include up to 20000 gene symbols.
When the system is operated in this mode, the TS-REX
database is bypassed, and TS-REX identiﬁes TF-encoding
genes among all genes present in the auxiliary ﬁle, and
those are then highlighted in the TF-gene network. An
example of a TS-REX auxiliary ﬁle is provided in
Supplementary Figure 2.
TS-REX input ﬁles that correspond to the Polycomb
group gene analysis (see ‘Discussion’) are provided in
the Supplementary Data:
  Supplementary File 1 contains data obtained using
MotifScanner. This information corresponds to
TFBS prediction results for human EZH2, SUZ12
and BMI1 as described in ‘Materials and Methods’.
  Supplementary File 2 is an alternative input ﬁle that
reports target genes and TRANSFAC identiﬁers of
predicted TFs as a two-column tab delimited text ﬁle.
This makes it possible to provide TFBS prediction
results obtained using another method than
MotifScanner as input to TS-REX.
Network viewer. The network viewer is the TS-REX
module that parses the user-provided primary input ﬁle
and visualizes the corresponding TF-gene network
before and after the selection of tissues or cell types.
Target genes, TF genes and TF proteins are represented
as nodes with diﬀerent shapes and colors (Supplementary
Figure 3). Network links correspond to relations between
TF-encoding genes and encoded TF proteins, and to rela-
tions between predicted TF proteins and target genes. The
concepts corresponding to a TF and to a network node
representing a TF will be used interchangeably in the fol-
lowing. The network viewer is automatically started once
the input ﬁle has been uploaded to the TS-REX server.
Node labels are obtained by merging the UniGene gene
symbol (for either TF-encoding or target genes) or the TF
name from TRANSFAC with the corresponding
UniGene or TRANSFAC TF identiﬁer. This choice
was driven by the need to use distinct labels for diﬀerent
nodes in the network, since multiple UniGene identiﬁers
may be associated with the same gene symbol, and multi-
ple TRANSFAC TF identiﬁers may correspond to the
same TF protein. Moreover, displaying both factor names
and TRANSFAC TF identiﬁers makes it possible for the
user to retrieve information for factors of interest from
TRANSFAC while preserving the readability of the
TF-gene network.
Zooming and panning are possible, as is the search for
nodes whose label contains a user-speciﬁed string, in order
to allow users to quickly spot the position of genes or TFs
of interest. Factors satisfying user-speciﬁed selection cri-
teria, e.g. those that are present in a given tissue or cell
type, are highlighted by coloring them red (see section
below on ‘Tissue browser’).
An overview of the functionalities that TS-REX pro-
vides in terms of network visualization is given in
Supplementary Figure 3, which displays the TS-REX net-
work viewer: node shapes and colors are diﬀerent for
target genes (pink squares), predicted TF proteins (light-
blue circles), and TF-encoding genes (green squares). The
text area allowing the user to search for genes or factors
whose name contains a given string is also visible, as
well as buttons for zoom and pane operations.
The ﬁgure demonstrates the use of the gene/factor
search functionality after zooming in and translating the
main network view to a region on the right-hand side of
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results are colored yellow.
The CPU performance of the algorithm depends on the
size of the dataset. When the number of binding site pre-
dictions in the primary input ﬁle exceeds a given threshold
(which was set to 10000 as a result of tests under diﬀerent
conditions), TS-REX does not allow visualization of the
corresponding TF-gene network, which would be too
large to be interactively rendered without signiﬁcantly
degrading software performance. However, the communi-
cation between software and database, the identiﬁcation
of TFs present in or speciﬁc to given anatomical structures
and the possibility to export results to ﬁles are still func-
tional. Data exported in tabular format can then be used
as a reﬁned input ﬁle (thus replacing the original input ﬁle
by one containing only predicted TFs that satisfy a given
anatomical selection), whose size would be suitable for
interactive visualization.
Tissue browser: selection of tissue and cell type groups. The
tissue browser is the TS-REX module that allows the user
to explore the TS-REX hierarchical classiﬁcation and to
choose anatomical structures to be used to identify tissue-
speciﬁc TFs in the TF-gene network that corresponds to
the user-provided primary input ﬁle. It is started after the
network viewer by using the ‘Tissue ﬁlter’ button. TS-
REX subsequently pinpoints which of the predicted TFs
in the analyzed dataset meet the speciﬁed selection criteria.
Users can choose whether they want TS-REX to identify
predicted TFs present in or speciﬁc to the selected ana-
tomical categories; transcripts-per-million (TPM) or
p-values from the TS-REX database are used by the
system according to this choice, as described in
‘Materials and Methods’. For the sake of completeness,
TS-REX also allows identiﬁcation of those TFs that are
not present in the selected anatomical structures.
In general, both options (presence and speciﬁcity) are
available. However, when an auxiliary ﬁle is provided, the
tissue browser does not allow identiﬁcation of tissue-spe-
ciﬁc TFs, but only considers the presence of TF-encoding
genes in this ﬁle. Each column in the auxiliary ﬁle must
contain a header reporting the name of the corresponding
tissue or cell type; this name is then displayed in the tissue
browser in order to allow the user to select tissues of inter-
est (Supplementary Figure 2).
TS-REX allows selection of pathologies, systems,
organs, tissues or cell types, or combinations of those.
When more than one item in the hierarchy is selected,
the search in the TS-REX database is carried out corre-
sponding to a logical OR of those categories, e.g. those
TFs that are present in or speciﬁc to at least one of the
selected tissues or cell types are identiﬁed and are high-
lighted in the TF-gene network.
The tissue browser includes a set of buttons that allow
the user (i) to highlight the relevant subnetwork, i.e.
change the graphical appearance of those nodes that cor-
respond to TFs satisfying the selection criteria, (ii) to
restore the default state of the graphical representation
of the network or of the tree corresponding to the hierar-
chical classiﬁcation or (iii) to export data to diﬀerent ﬁles.
Figure 3 demonstrates the use of the tissue browser to
identify TF proteins present in given anatomical structures
with reference to the human classiﬁcation. In this example,
glioma, glioblastoma and oligodendroglioma are selected
as tissues of interest. The number of EST libraries corre-
sponding to this selection is displayed in red, in order to
allow the user to critically evaluate the reliability of the
results.
TS-REX makes it possible to ﬁne-tune the TPM or
p-value threshold used for the identiﬁcation of which
TFs meet the selection criteria (see ‘Materials and
Methods’), in order to allow users to change the deﬁnition
of presence or speciﬁcity according to particular require-
ments. For instance, this additional layer of control could
be used to investigate varying degrees of tissue speciﬁcity
of diﬀerent TFs in a TF-gene network. In general, the
Figure 3. Use of the tissue browser window to select anatomical struc-
tures, in this case human glioma, glioblastoma and oligodendroglioma
tissues. More generally, users can select anatomical structures belonging
to diﬀerent levels in the hierarchy (1). Whenever more than one item is
selected in the tissue browser, those TFs that meet the selection criteria
for either of them are identiﬁed by the software and the corresponding
nodes are highlighted in the network. In general, it is possible to iden-
tify TFs that are either present in or speciﬁc to given tissues or cell
types (2); in both cases, a threshold level (TPM in case of presence,
p-value in case of speciﬁcity) has to be speciﬁed by the user (3). The
number of EST libraries in the TS-REX database that correspond to
the anatomical selection performed is also indicated (4). A set of but-
tons allows the user to highlight network nodes that correspond to
those TFs that meet the selection criteria, or to export data to diﬀerent
ﬁles (5).
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to a set of factors still exhibiting diﬀerent degrees of spe-
ciﬁcity, a piece of information that would be lost if only
one ﬁxed p-value threshold could be used. On the other
hand, selecting lower p-value thresholds makes it possible
to pinpoint which factors are more speciﬁc among those
that were initially identiﬁed. The results provided by TS-
REX in terms of which TFs are present in or speciﬁc to a
given tissue or cell type always depend on a user-speciﬁed
threshold, and choices of transcript-per-million and
p-value thresholds are independent from each other.
Selection of TFs based on their enrichment in specific tissues
or cell types. The quantitative estimates stored in the
TS-REX database (TPMs or p-values) or, alternatively,
tissue-related information contained in the user-provided
auxiliary ﬁle are used to identify which TFs in the TF-gene
network under investigation meet the selection criteria
speciﬁed by the user. The corresponding network nodes
are colored red in order to facilitate visual inspection, as
exempliﬁed in Figure 4A, where TFs present in human
glioma, glioblastoma or oligodendroglioma in the
Polycomb group TF-gene network are identiﬁed.
Figure 4B displays the network containing only the high-
lighted TF nodes from Figure 4A, and was obtained using
one of the ﬁles exported from TS-REX using the ‘Export
selected’ functionality (see ‘Data export’), similar to the
one that is exempliﬁed in Supplementary File 5 (see ‘Data
export’). This ﬁle contains a correspondence between
target genes and TRANSFAC identiﬁers of predicted
TFs, restricted to highlighted TFs.
Data export. Data export is a crucial component of TS-
REX that allows users to save data to diﬀerent ﬁles in
order to (i) inspect those TPMs or p-values that underlie
the identiﬁcation of relevant TFs as graphically displayed
by the network viewer and to (ii) use data for further
analysis. This allows TS-REX to be used in the context
of user-deﬁned analytical pipelines, downstream from
existing binding site prediction tools, and upstream of sub-
sequent processing. An example could be the generation of
summarizing statistics on those TFs that are present in or
speciﬁc to a given cell type in the context of a predicted
TF-gene network for target genes of interest.
TS-REX includes two distinct export procedures, both
related to those TFs that were highlighted as relevant to
the selection performed, e.g. present in or speciﬁc to a
given tissue or cell type: (i) ‘Export selected’ and (ii)
‘Export p-values/TPMs’ (Figure 3). Examples of ﬁles
exported from TS-REX are provided as supplementary
data.
Option (i) allows users to save the following three ﬁles:
(a) an extract from the primary input ﬁle restricted to
highlighted TFs, including lists of TRANSFAC matrix
identiﬁers corresponding to predicted binding sites
(Supplementary File 3; this information is only available
when the primary input ﬁle is an output ﬁle from
MotifScanner), (b) a list of the UniGene EST library iden-
tiﬁers underlying the current selection, including an
Figure 4. View of TF-gene networks from the Polycomb group gene analysis. (A) Portion of the Polycomb group gene network after the identi-
ﬁcation of those TFs that are present in human glioma, glioblastoma or oligodendroglioma (TPM threshold=100). Nodes corresponding to those
TFs that meet the selection criteria are colored red. Squares and circles correspond to genes and TFs, respectively. Target and TF-encoding genes can
be distinguished based on their color: the former are pink, the latter are green. (B) Portion of the corresponding subnetwork including only TF
proteins present in glioma, glioblastoma or oligodendroglioma. This sub-network was obtained using one of the TS-REX exported ﬁles correspond-
ing to the network in Figure 4A (see Results), namely a ﬁle that is similar to Supplementary File 5.
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which libraries (Supplementary File 4) and (c) a ﬁle con-
taining the correspondence between target genes and
TRANSFAC identiﬁers of predicted TFs, restricted to
highlighted TFs (Supplementary File 5). The latter ﬁle
can be used as input to TS-REX in order to visualize
that portion of the original TF-gene network that includes
highlighted TFs only.
Option (ii) allows users to save those TPMs or p-values
that underlie the identiﬁcation of which TFs meet the
selection criteria speciﬁed, i.e. those numerical values
that were internally used by the system in order to high-
light TFs in the network (Supplementary File 6).
Prediction of TFs regulating genes, which encode
Polycomb group proteins in different tumor types
and embryonic stem cells
We used TS-REX to support the identiﬁcation of so far
unknown TFs controlling the expression of the Polycomb
group protein encoding genes EZH2, SUZ12 and BMI1 in
seven diﬀerent human tissues, for which an over-expres-
sion and/or functional importance of these genes has pre-
viously been shown: breast cancer, prostate cancer, colon
cancer, glioma, neuroblastoma, lymphoma and human
embryonic stem cells. The use of TS-REX allowed rejec-
tion of up to 92% of the TF candidates originally pre-
dicted using TOUCAN, as detailed in Table 2, where
the numbers of selected EST libraries for the diﬀerent
tissues are also indicated.
In a ﬁrst step, we identiﬁed conserved genomic DNA
sequences of approximately 2000bp around the
transcriptional start site of the three genes in human and
mouse using VISTA (17) and then determined TF-binding
sites within these sequences using MotifScanner version
3.1.1 (2,7,22,23).
Binding sites present both in the murine and in the
human sequence of each gene were identiﬁed, the resulting
data were fed into TS-REX, and predicted TFs present in
the six human tumor tissues and in human ES cells were
identiﬁed using a TPM threshold of 100. The complete
results, including the number of binding sites for all TFs
predicted to regulate EZH2, SUZ12 and BMI1 in the dif-
ferent tissues, are provided as individual tab delimited text
ﬁles for each tissue (breast cancer, Supplementary File 7;
colorectal cancer, Supplementary File 8; ES cells,
Supplementary File 9; glioma, Supplementary File 10;
lymphoma, Supplementary File 11; neuroblastoma,
Supplementary File 12; prostate cancer, Supplementary
File 13).
Summarizing statistics on predicted TFs upstream of
EZH2, SUZ12 and BMI1 in the diﬀerent tissues are
reported in Table 3 and in Supplementary Table 1. For
each target gene, Supplementary Table 1 lists all predicted
TFs, together with the corresponding numbers of TFBSs;
occurrences of individual TRANSFAC matrices are sep-
arately counted and reported as comma-separated
sequences. The tissues in which each TF is present are
also included. In order to present the most frequent TFs,
Table 3 shows those TF proteins that are present in at least
three out of the seven tissues of interest in this analysis, and
for which at least three TRANSFAC matrix identiﬁers
are predicted in promoters of at least two target genes.
Table 2. Summary of false positive rejection rates achieved with TS-REX in the PcG analysis
Tissue Number of selected
EST libraries
a
Target gene Number of TFs predicted
with TOUCAN
b
Number of false positives
excluded by TS-REX
c
Rejection rate (%)
d Average rejection
rate (%)
e
BC 594 BMI1 246 212 86 85
EZH2 300 253 84
SUZ12 346 298 86
CC 680 BMI1 246 190 77 80
EZH2 300 248 83
SUZ12 346 281 81
ES 7 BMI1 246 220 89 90
EZH2 300 273 91
SUZ12 346 315 91
GL 26 BMI1 246 170 69 73
EZH2 300 220 73
SUZ12 346 266 77
LY 12 BMI1 246 167 68 68
EZH2 300 199 66
SUZ12 346 243 70
NB 13 BMI1 246 220 89 90
EZH2 300 268 89
SUZ12 346 320 92
PC 139 BMI1 246 175 71 72
EZH2 300 217 72
SUZ12 346 248 72
BC: breast cancer; CC: colon cancer; ES: embryonic stem cell; GL: glioma; LY: lymphoma; NB: neuroblastoma; PC: prostate cancer.
aThe numbers of EST libraries corresponding to each tissue selection.
bFor each tissue and for each target gene, the initial numbers of TFs predicted using MotifScanner.
cThe numbers of false positives excluded by TS-REX based on a TPM threshold of 100.
dPercentage of rejected TFs with TPM counts lower than 100.
eAverage rejection rates of predicted TFs upstream of BMI1, EZH2, and SUZ12 for individual tissues.
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binding of EGR1 to EZH2, SUZ12 and BMI1 promoter
sequences. In addition, we investigated whether over-
expressing EGR1 aﬀects the expression of the three
target genes in a colorectal cancer cell line (SW480) and
in a cervical cancer cell line (Hela). EGR1 EST counts of
human colorectal cancer tissues were much higher
(TPM=222.33) than those of human cervical carcinoma
tissues (TPM=25.01). SW480 and Hela cells are not
represented in the TS-REX database for reasons explained
Table 3. Summarizing statistics on predicted TFs upstream of EZH2, SUZ12 and BMI1 in the diﬀerent tissues of interest in this
analysis
Transcription factor BMI1 EZH2 SUZ12 Present in
AhR 2,2 2,2 1 GL,LY,PC
DEC1 2 1 BC,CC,GL,LY,PC
DP-1 2,2,2 2,2,2,2,2 2,2,2,2,2 BC,CC,GL,LY,PC
E12 2 2,2,2,1 CC,GL,LY,PC
E47 2 2,2,1 CC,GL,LY,PC
Egr-1 1,2,2 2,2 2,1 CC,GL,PC
Fra-2 1 1,2,2 CC,GL,LY
HIF-1alpha 2,1,2 1,2,2 1,1,1 BC,CC,ES,GL,LY,NB,PC
HIF-1alpha-isoform1 2,1,2 1,2,2 1,1,1 BC,CC,ES,GL,LY,NB,PC
HMG I 1 1 2,2 BC,CC,ES,GL,LY,NB,PC
HMG-Y 1 1 2,2 BC,CC,ES,GL,LY,NB,PC
HTF4 2 2,1 BC,CC,GL,NB,PC
HTF4gamma 2 2,1 BC,CC,GL,NB,PC
IRF-1 1,1,1 2,2 CC,LY,PC
ITF-1 2 2,1 CC,GL,LY,PC
ITF-2 2 2,1 GL,LY,NB,PC
MAZ 2 2 1 BC,CC,ES,GL,LY,NB,PC
MRF-2-isoform1 2 2,1 CC,GL,LY,PC
NF-YC-3 1 2 2,2 BC,ES,GL,LY
PEA3 2 1,2 CC,ES,GL
POU2F1 2 2,1,2,1,1 GL,LY,NB
RAR-alpha 2 2,2 2 BC,GL,NB,PC
RAR-alpha1 2 2,2 2 BC,GL,NB,PC
RXR-beta 2 2,2 2 GL,LY,PC
SEF2-1B 2 2,1 GL,LY,NB,PC
STAT1 2,1 2,2 2,2,2 BC,CC,GL,LY,PC
STAT3 2 2 2,2 BC,CC,GL,PC
STAT6 1,1 2,2 2,2,2 BC,CC,LY,PC
Smad2 (437 AA) 2 1 GL,LY,PC
Smad2-L 2 2,2 2,1 GL,LY,PC
Smad3 2 2,2 2,1 CC,ES,GL
Smad4 2 2,2 2,1 BC,ES,LY
Smad4delta3 2 1 BC,ES,LY
Smad4delta4-6 2 1 BC,ES,LY
Smad4delta4-7 2 1 BC,ES,LY
Smad4delta5-6 2 1 BC,ES,LY
Smad4delta6 2 1 BC,ES,LY
Sp1 2,2,2 2,2,2 1,2,2 CC,ES,LY
T3R-alpha 2 2 2 CC,GL,NB,PC
T3R-alpha1 2 2 2 CC,GL,NB,PC
T3R-alpha2 2 2 2 CC,GL,NB,PC
USF2 2,2,2 2,2,1 1 GL,LY,PC
USF2a 2,2,2 2,2,1 1 GL,LY,PC
USF2b 2,2 2,1 GL,LY,PC
YY1 1,1,2,2 1,1,1 1 CC,LY,PC
c-Ets-2 1,2 2,2 CC,GL,LY
c-Fos 1,1 1,1,1,2,2 BC,CC,GL,LY,NB,PC
c-Jun 1,1 1,1,1,2,2 CC,GL,PC
c-Myb 1,1,1 2,2,2 2,2,2 BC,LY,PC
c-Myb-isoform1 1,1,1 2,2,2 2,2,2 BC,LY,PC
c-Myc 1,1,2,2,1,2 2,1 1,1 CC,GL,LY,PC
p53 2 2 BC,CC,GL,LY,NB,PC
p53-isoform-1 2 2 BC,CC,GL,LY,NB,PC
This list is restricted to those TFs that are present in at least three out of the seven tissues analyzed, and for which at least three
TRANSFAC matrix identiﬁers are predicted in promoters of at least two target genes. For each TF, numbers of predicted
TFBSs are indicated, separating diﬀerent TRANSFAC matrices and reporting the corresponding numbers of occurrences as
comma-separated sequence, together with the list of tissues in which that TF is present. Complete statistics are provided in
Supplementary Table 1. BC: breast cancer; CC: colon cancer; ES: embryonic stem cell; GL: glioma; LY: lymphoma; NB:
neuroblastoma; PC: prostate cancer. TF names are derived from TRANSFAC.
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generation process, but qPCR experiments showed a com-
parable diﬀerence in EGR1 transcript levels (Figure 5A).
This expression diﬀerence was less considerable at the pro-
tein level (Figure 5B). Chromatin immunoprecipitation
experiments revealed that EGR1 binds to genomic regions
of all three target genes in which EGR1-binding motifs are
present (Figure 5C and D). EGR1 binding to the three
target genes is enhanced by phorbol 12-myristate-13-
acetate (PMA) stimulation and by EGR1 over-expression.
However, transient over-expression of this single TF did
not lead to a signiﬁcant change of expression of the three
genes in SW480 and Hela cells as judged by qPCR mea-
surements (data not shown), suggesting that additional
factors act in combination with EGR1, with several can-
didate TFs being presented in this study.
DISCUSSION
We have developed a novel database/software resource
for the tissue and cell type-speciﬁc dissection of TF-gene
networks based on a newly established hierarchical
anatomical classiﬁcation of human and mouse UniGene
ESTs and on quantitative estimates of gene expression
levels.
Our approach oﬀers distinct advantages in comparison
to similar tools, which combine TFBS information with
gene expression data. Even though MatInspector (8,9)
Figure 5. (A) EGR1 transcript levels in SW480 and Hela cells determined by qPCR. The vertical axis shows EGR1 expression diﬀerences relative to
the reference gene B2M. Mean values and the standard deviation of three measurements are shown. (B) Detection of human EGR1 protein (82kDa)
in Hela and SW480 cells transfected with empty vector (CMV) or with EGR1 expression vector (EGR1) using western blot analysis. b-Actin levels
served as loading control (bottom). (C, D) EGR1 binding to EZH2, SUZ12 and BMI1 promoter sequences. SW480 and Hela cells were
(C) transiently transfected with empty vector (CMV) or with EGR1 expression vector (EGR1), or alternatively (D) treated with PMA or left
untreated. Chromatin was precipitated using antibodies against EGR1, IgG or no antibody (no Ab), and analyzed by PCR. Diﬀerent primer
pairs for EZH2 (AE), SUZ12 (AF, Q) and BMI1 (AB, AC) are indicated. Results are presented as the ratio of immunoprecipitate (IP) over
total input DNA utilized. Error bars show the standard deviations of three diﬀerent PCR reactions.
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associations of TFs, these associations do not represent
quantitative expression levels, as they are based on infor-
mation from published article abstracts, and they are not
as ﬁne grained and structured as the TF gene expression
information provided by TS-REX. The Promoter Analysis
Pipeline (10,11) and the method by Jeﬀery et al. (12) pre-
dict TFBSs in genomic regions of target genes, which
share similar expression patterns. In contrast, TS-REX
focuses on the tissue and cell type-speciﬁc expression of
predicted TF genes to extract those TFs, which match the
expression of their target genes. Although Jeﬀery and col-
leagues (12) demonstrate the integration of TF gene
expression data, such data are not accessible to the user
and are not structured as they are in TS-REX. Cytoscape
(24) has a broader and diﬀerent scope than TS-REX,
which makes a direct comparison diﬃcult. However,
even though the modular architecture of Cytoscape
allows it to make use of diﬀerent external data sources
and annotation datasets, one characteristic feature of
TS-REX is the fact that its novel anatomical classiﬁcation,
its EST abundance database, and its interface with TF-
binding site prediction functionalities provided by
TOUCAN are all part of a uniﬁed design.
The TS-REX database and software resource was used
to predict regulators of Polycomb group genes in six
human tumor tissues and in human embryonic stem
cells. Since TS-REX enables a tissue and cell type-speciﬁc
screen based on TF gene expression levels, it was possible
to ﬁlter out a large number of irrelevant predictions (up to
92%), which allowed us to focus on those that are of
potential functional importance and represent interesting
candidates for further experimental testing. Polycomb
group proteins form complexes of diﬀerent composition,
which primarily act as negative regulators of gene expres-
sion by means of chromatin alterations (25–29). Besides
the important role of PcG proteins in maintaining spatial
patterns of gene silencing during development, they are
critically involved in regulating mammalian stem and
cancer cells (30,31). Within the cancer research ﬁeld, an
increasing number of reports supports a role of PcG pro-
teins, in particular EZH2, SUZ12 and BMI1, in tumor
development and in the maintenance of tumor-initiating
cells. These genes are frequently over-expressed in cancer
as compared to normal tissue, high expression levels cor-
relate with poor patient prognosis in certain cancer types,
and gene perturbation experiments have revealed their
involvement in the generation and maintenance of tumor-
igenic cells (27,31,32).
Furthermore, recent ﬁndings led investigators to suggest
that PcG target genes, including several known tumor sup-
pressor genes, might be particularly prone to stable silenc-
ing in stem cells as a critical step during cancer
development (33–35). These results were also interpreted
as support for a stem cell origin of cancer, for which
experimental evidence has so far been provided in certain
cancer types (36,37).
The molecular mechanisms of PcG gene over-
expression in diﬀerent tumor types remain largely unre-
solved except for some cases of gene ampliﬁcation and few
upstream acting factors identiﬁed in certain cell types.
Although several published and ongoing studies in the
ﬁeld of stem cell and cancer research focus on identifying
PcG target genes, comprehensive knowledge about
upstream TFs acting in diﬀerent tissues and cell types is
missing.
Our study revealed interesting novel predictions besides
already known upstream acting factors, thus validating
the applied approach (Table 3 and Supplementary
Table 1). Factors that are known to regulate one or
more of the three target genes are E2F TFs (38–43), p53
(44), TFs of the GLI-Kru ¨ ppel family to which YY1
belongs (45,46), MYC family TFs (47–49) and TCF4
(50). Several newly predicted conserved binding sites in
the studied genomic sequences of EZH2, SUZ12 and
BMI1, which are bound by TFs present in many of the
six tumor tissues and embryonic stem cells, are particu-
larly interesting (see Table 3 and Supplementary Table 1).
EGR1, HIF1A, DEC1 and ATF4 are hypoxia-inducible
TFs, and accumulating experimental evidence supports a
role for hypoxia in regulating normal stem cell and cancer
cell functions (for review see 51). In this study, we dem-
onstrate the binding of EGR1 to all three tested Polycomb
group gene promoters, which is enhanced by PMA stim-
ulation and EGR1 over-expression. Our results suggest
that Polycomb group protein genes could be involved in
hypoxia-mediated regulation of stem cell and cancer cell
functions, which could be investigated more thoroughly in
future studies.
In summary, we have presented a tool that allows
extraction and visualization of TF-gene interactions,
with a focus on identifying those TFs that are present in
tissues or cell types of interest, in order to reduce false
positive rates in TFBS prediction.
Its ﬂexibility (i) in identifying TFs either present in or
speciﬁc to tissues or cell types of interest using a ﬁne-
grained hierarchical anatomical classiﬁcation, (ii) in ﬁne-
tuning tissue selection parameters and (iii) in exporting
TPMs/p-values to text ﬁles for further analysis, makes
TS-REX a valuable novel resource for analysis and visu-
alization of tissue and cell type-speciﬁc TF-gene interac-
tions. TF gene expression levels are currently only based
on EST counts, and individual cell types or cell lines
might not be suﬃciently covered by EST libraries
in UniGene or might not be included in the TS-REX
database for reasons mentioned in ‘Materials and
Methods’. However, the modular architecture of TS-
REX enables a future integration of additional datasets,
e.g. microarray and chromatin immunoprecipitation data.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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